Welcome to the Karanicolas lab

 
 

Our primary goal is to develop structure-based approaches for modulating protein function using small-molecules. We apply these new approaches in projects seeking to re-activate disabled tumor suppressors, inhibit oncogenic RNA-binding proteins, and tune the activity of antibodies used in cancer immunotherapy.

 

Harnessing the power of computational chemical biology to address non-traditional drug targets